Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
Sally M Amos, Hollie J Pegram, Jennifer A Westwood, Liza B John, Christel Devaud, Chris J Clarke, Nicholas P Restifo, Mark J Smyth, Phillip K Darcy, Michael H Kershaw
Cancer Immunology, Immunotherapy | SPRINGER | Published : 2011
This work was supported by the National Health and Medical Research Council of Australia (NHMRC), Cancer Council of Victoria and The Bob Parker Memorial Fund. M.K. is supported by a Senior Research Fellowship from the NHMRC. P.D. is supported by an NHMRC Career Development Award, M.J.S. is supported by an Australia Fellowship from the NHMRC and S.A. is supported by a Cancer Council of Victoria Postgraduate Cancer Research Scholarship.